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Abstract A new perspective is emerging indicating that
mitochondria play a critical role in aging not only because they
are the major source and the most proximal target of reactive
oxygen species, but also because they regulate stress response
and apoptosis. Recent literature indicates that, in response to
stress, a variety of molecules translocate to and localise in
mitochondria. These molecules are likely to interact with each
other, in order to mediate mitochondria/nucleus cross-talk and to
regulate apoptosis. We surmise that an integration of signals in
multimolecular complexes occurs at mitochondrial level. These
phenomena can be of critical importance for human aging and
longevity. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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Progressive loss of mitochondrial function in several tissues
is a common feature of aging. More in general, it has been
proposed that mitochondria can be considered as a sort of
biological clock for cell timing and aging. According to the
hypothesis of Harman and its further extensions, life-long
production of reactive oxygen species (ROS) as by-products
of oxidative metabolism leads to the accumulation of DNA
and protein damages at multiple cellular and tissue levels.
This eventually induces the appearance of the aged pheno-
type, at both cellular and organismal level [1^3]. In line with
this theory, several experimental evidences indicate that mito-
chondria are a major target of the aging process. In particu-
lar:
b an accumulation of large deletions and point mutations in
mitochondrial DNA (mtDNA) have been described in aged
individuals [4,5] and a decrease in the number of mtDNA
copies in some tissues has been reported [6];
b a decrease with age of the electron transport chain enzyme
activity has been described in lymphocytes [7], skeletal
muscle cells [6] and cardiomyocytes [8] ;
b as a consequence of such a gradual impairment of the res-
piratory function, an increased ROS production has been
reported in a variety of tissues [9] ; even if it seems that the
e¡ect of oxidative stress on mitochondria may have been
overestimated [10], a progressive peroxidation has been de-
scribed in membranes [11] and in both mitochondrial and
nuclear DNA [12] of aged subjects;
b changes in mitochondrial morphology and a decreased mi-
tochondrial membrane potential (MMP), the driving force
for ATP synthesis, in aged tissues have been reported [13].
It is thus well established that mitochondrial function
undergoes deep changes during aging, and these changes
have to be considered causal events of the aged phenotype,
rather than consequences, as suggested by the following ob-
servations:
b cells from young rats undergo rapid senescence and degen-
eration when microinjected with mitochondria extracted
from ¢broblasts of old rats [14,15];
b ROS production induced by V21Ras transfection in human
¢broblasts induces replicative senescence [16] ;
b an inverse relationship exists between the rate of mitochon-
drial hydroperoxide production and the maximum life span
of species [17,18] ;
b the administration of antioxidant compounds such as N-
acetyl cysteine [19], GSH [20], and vitamin C [21] is able
to eliminate the mitochondria-induced oxidative stress and
provokes an increase of mean and maximum life span; the
administration of acetyl-L-carnitine is also able to partially
restore some metabolic parameters in old rats, such as car-
diolipin content in mitochondrial membranes and metabolic
activity [22].
Di¡erences in mitochondrial function can be very impor-
tant for attaining successful or unsuccessful aging. Recently, it
has been demonstrated that an mtDNA germline inherited
variant (haplogroup J) is associated with successful aging
and longevity in Italian population [23,24]. Moreover, in Jap-
anese people, three associated mtDNA germline mutations
have been found at higher frequency in centenarians than in
controls [25]. Recently, mitochondrial germline variability as-
sociated with longevity has been suggested to reduce the rate
of age-associated accumulation of mitochondrial mutations in
somatic cells, adding further evidence to the general hypoth-
esis that speci¢c mitochondrial inherited variability can con-
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tribute to longevity by conferring resistance to diabetes and
atherosclerosis [26]. On the other side, it has been reported
that patients su¡ering from multiple sclerosis or DIDMOAD,
a rare human disease characterised by diabetes insipidus and
mellitus, optic atrophy and deafness, show the prevalence of
mitochondrial haplogroup T [27,28]. A relationship between
mtDNA haplogroups and mitochondrial function has been
demonstrated. In particular, a study on human spermatozoa
motility [29] showed that mtDNA haplogroup T is correlated
with a less e⁄cient oxidative phosphorylation. Moreover, it
has been demonstrated that sperm cells with depolarised mi-
tochondria show a defective nuclear maturity [30]. By exten-
sion, it can be speculated that mtDNA haplogroups having
di¡erent properties related to oxidative phosphorylation or
other mitochondrial functions (such as control of apoptosis)
may be associated with physiological or pathological condi-
tions allowing the subject to reach or not extreme longevity.
Hence, it is possible to hypothesise a more general relation-
ship among mtDNA haplogroups, mitochondrial function
and aging or longevity.
Another important point has to be taken into account when
the relationship between mitochondria, aging and longevity is
considered. We surmise that not only the energetic request of
the cell but also many other stimuli are conveyed to mito-
chondria, that in turn can adjust their metabolism and func-
tions in response to this information £ow. Accordingly, nu-
clear gene expression has to be regulated on the basis of the
status of the cell, including energy availability. Thus, mito-
chondria are likely involved in the control of the aging process
not only because they are the ‘power plant’ of the cell and the
major source of ROS, but also because they may regulate
nuclear gene expression. In other words, it has to be expected
that a reversal information £ow exists from the mitochondria
to the nucleus as a consequence of changes occurring in the
status of mitochondria. Accordingly, it has been found that a
number of proteins with regulatory or adaptive role are pri-
marily located in these organelles or translocate therein when
activated. This is the case of Nur77/TR3 [31], p53 [32], PKCN
[33], JNK/SAPK [34], some caspases and cytoplasmic mem-
bers of Bcl2 family, such as Bid, Bax, Bim [35^37]. On the
other hand, a variety of signals originate from mitochondria
and directly or indirectly induce biochemical pathways with
cytoplasmic or nuclear targets. In this perspective, ATP [38]
and ROS [39] might be considered as messenger molecules. In
particular, ROS can activate the ASK1-mediated apoptotic
pathway [40], the p70(S6k)-mediated progression of cell cycle
[41] and the induction of various transcription factors (AP-1,
AP-2, NFUB) via the antioxidant response element (ARE)
[39]. This sort of informational net is depicted in Fig. 1.
The supposed path from mitochondria to the nucleus might
functionally resemble the one present in Saccharomyces cere-
visiae and called ‘retrograde response’, which informs the cell
on the organelle’s status. Retrograde response involves several
nuclear-encoded proteins located in the mitochondrion and in
the cytoplasm. Multiple longevity genes have been isolated
and some of them are involved in metabolic regulation and
Fig. 1. Information £ow from the cell to the mitochondrion and from the mitochondrion to the cell. A variety of signalling pathways (red ar-
rows) converge to the mitochondrion, while other signals (green arrows) originating from the mitochondrion are directed to cytoplasmic and
nuclear targets. JNK/SAPK, c-Jun NH2-terminal kinase, or stress activated protein kinase, which can inactivate the antiapoptotic protein Bcl-
xL; Ras, a family of GTP-binding proteins, which move in/out of mitochondria in response to various stress; Bax, Bid, Bim, cytoplasmic mem-
bers of Bcl-2 family that modulate the apoptotic cascade together with other Bcl-2 family members; PKCN, a protein kinase CN with a proap-
optotic activity; p53, a transcription factor which induces multiple pathways of apoptosis; TR3/Nur77, an intracellular steroid receptor with a
proapoptotic activity; caspases, proteases involved in apoptosis; some of them (e.g. caspase 7) can act at mitochondrial level; ASK1, apoptosis
signal-regulating kinase 1, a MAP kinase able to activate the JNK pathway; p70(S6k), growth factor-regulated protein kinase (S6 kinase) which
induces cell cycling; ARE, antioxidant response element; AP-1, AP-2, NFUB, nuclear transcription factors that are involved in gene expression
during apoptosis; Ras^Rtg pathway, controls stress resistance and life span in S. cerevisiae ; Daf pathway, controls stress resistance and life
span in C. elegans ; Clk-1/Coq7, a mitochondrial protein involved in ubiquinone synthesis; proapoptotic molecules, cytochrome c, AIF, procas-
pases, Smac/Diablo, the release of whom induces nuclear apoptosis.
FEBS 24642 5-3-01 Cyaan Magenta Geel Zwart
S. Salvioli et al./FEBS Letters 492 (2001) 9^1310
have mitochondrial localisation (PHB1 and PHB2, RAS1 and
RAS2) or interact in the retrograde regulatory pathway (Rtg
1, 2 and 3) [42]. Similarly, in Caenorhabditis elegans clk-1 gene
encodes a protein with mitochondrial localisation that is
highly conserved among eukaryotes and determines the timing
of embryonic and postembryonic development, adult worm
behaviour, reproduction and aging [43,44]. Mutations in clk-
1 determine the so-called clk-1 phenotype, characterised by a
slower metabolic rate and prolonged life span. Clk-1 shares a
tight homology with the yeast gene coq7, that is a regulator of
mitochondrial function, important for the change from fer-
mentative to respiratory metabolism in yeast [45]. It seems
that CLK-1 in C. elegans is somehow involved in informing
the nucleus when energy production slows down. As a result,
a pattern of gene expression is implemented that renders the
cell able to cope with a low energetic availability. This will in
turn result in slow physiological rates and thus prolonging life
span.
Thus, it can be predicted that coq7, in analogy to clk-1
would act as a longevity gene, slowing the metabolic rate of
the yeast from respiration (fast) to fermentation (slow). Intri-
guingly, the extension of life by caloric restriction also relies
on mitochondrial function, but it seems to involve pathways
distinct from retrograde response [46]. Hence, a multifaceted
role of mitochondria in human aging has to be expected.
Mitochondrial control of apoptosis is extremely important
for many if not all the cell death pathways [47^49]. This con-
trol is often deranged in aged cells, where an increased sus-
ceptibility to ROS production has been reported. In fact, ROS
lower MMP, enable the triggering of permeability transition
(PT) reactions and the lowering of the threshold for calcium-
induced PT activation. This sequence of events results in ap-
optosis in lymphocytes, liver and brain from aged mouse [50].
In other cases, an increased resistance to apoptosis has been
observed in resting lymphocytes from aged people and cente-
narians with respect to young people, and in ¢broblasts which
underwent in vitro senescence [51,52]. This di¡erent behaviour
is likely dependent on the cell type and status (activated or
resting, proliferating or terminally di¡erentiated cells), on the
experimental model (in vivo or in vitro), and on the apoptotic
stimuli used. It can also be hypothesised that cells from aged
people are less prone to apoptosis because their mitochondria
have become ine⁄cient or more refractory in generating sig-
nals that induce apoptosis. This phenomenon could be con-
sidered as the consequence of the adaptation of cells to the
detrimental e¡ects of life-long exposure to oxidative stress. In
fact, the survival to a long term exposure to stressful condi-
tions is likely dependent upon the induction of protective
mechanisms, such as HSP proteins, which in turn allow cell
recovery after stress and impede cell to undergo apoptosis
[53]. This phenomenon would lead, on one hand, to the sur-
vival of the cells, and thus to longevity of the organism, and,
on the other hand, to the accumulation of damaged cells, and
thus to the appearance of the aged phenotype.
Fig. 2. Signal integration at the mitochondrial level. (1) Balancing between ROS production and antioxidant defences, in particular SOD2 activ-
ity, can in£uence the opening of mitochondrial megachannels. (2) Integration of death/life signals at permeability transition complex level. Mol-
ecules coming from both inside (Bcl-2) and outside (Ras, Raf, Bag-1, Grb10 and perhaps others) the mitochondrion can associate to form a
complex (the ‘mitochondrial signalosome’), which may regulate the opening of the mitochondrial megachannels. The stabilisation in an open
conformation will lead to a swelling of the matrix, breakage of the outer membrane, leaking of proapoptotic molecules and nuclear apoptosis.
On the contrary, if the complex keeps the megachannels closed, the cell will survive. (3) In some cases the integration phase can be bypassed
by molecules able to directly form pores in the outer membrane, allowing the proapoptotic compounds to freely di¡use in the cytoplasm. Bax,
for example, can form channels alone or in combination with porins (in this case the channel is large enough to allow the passage of cyto-
chrome c molecules). The truncated form of Bid may also form channels independently from Bax. Nevertheless, the channel-forming activity of
Bax may be regulated by the mitochondrial signalosome via Bad activity. BR, benzodiazepine receptor; ANT, adenosine nucleotide transporter;
AIF, apoptosis inducing factor; tBid, truncated Bid; p53, is found in mitochondria after apoptosis triggering, associated with the chaperone
protein HSP70 (see text); SOD2, mitochondrial superoxide dismutase.
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In addition to the role of ROS source, an emerging body of
evidence indicates a role of mitochondria in signal integration
and ampli¢cation. Indeed, as described above, a number of
signal and adapter proteins are found in mitochondria (Fig.
2). Most of them have physical interactions with other pro-
teins present in mitochondria [54,55], as in the case of the p53,
that is associated with mt hsp70, the major mitochondrial
import protein [32]. Moreover, some of these proteins, such
as Ras [54], Raf [56], Grb10 [57], Bag-1 [58], interact with
each other [58,59] and may form a multimolecular complex
that could act as a ‘mitochondrial signalosome’. The local-
isation of such a complex is at present unknown, but it may
be the same of Bcl-2, i.e. the membrane compartment, since
some of its components physically interact with Bcl-2 itself.
Alternatively, it could be placed on the outer face of the outer
membrane. Indeed, recent data suggest that this is the more
likely localisation for mitochondrial p53 [60] and, by analogy,
it could be the same of the mitochondrial signalosome. Such a
complex would be capable of integrating the signals brought
by each of its components. Taking into account that some of
the components of mitochondrial signalosome associate with
Bcl-2, it can be hypothesised that a major function of this
complex is to modulate the inner mitochondrial membrane
permeability to ions. When this permeability is lost, mito-
chondrial matrix swells, inner membrane cristae become £at
and the outer membrane will eventually break, leading to the
release in the cytoplasm of proapoptotic molecules that are
normally sequestered in the intermembrane space, such as
cytochrome c [61], AIF [62], Smac [63] and procaspases [64].
Another part of the regulation of apoptotic pathway driven
by mitochondrial signalosome may occur at the level of Bax/
Bcl-xL interaction. It is known that Bax can alter mitochon-
drial membrane permeability and induce apoptosis by forming
homodimeric Bax/Bax or heterodimeric Bax/porin channels
and that this activity is blocked by interaction of Bax with
Bcl-xL [65,66]. Bcl-xL can be blocked by the antiapoptotic
Bad, that, in turn, can be inactivated by Raf, which is thought
to be part of the mitochondrial signalosome. Thus, the apo-
ptotic control of the signalosome may extend also over the PT
complex.
Another candidate component of the mitochondrial signal-
osome is p66shc, a member of the shc adapter protein family.
It has been shown that targeted mutation of the mouse p66shc
gene prolongs life span, likely modulating the signal trans-
duction pathway that regulates stress apoptotic response to
H2O2 and increasing resistance to paraquat [67]. Another
role has been proposed for p66shc in apoptosis [68,69], namely
that it can act as an adapter protein able to stop mitosis and
initiate apoptosis after phosphorylation at particular amino
acidic sites. According to this theory, the phosphorylation
of p66shc would be triggered mainly by ROS. When the bur-
den of ROS damages is dramatically increased (as in the case
of aged individuals), the apoptotic cascade would predomi-
nate and determine the death of the whole organism. This
phenomenon has been named ‘phenoptosis’ [70]. Accordingly,
it can be hypothesised that p66shc function would have a pos-
itive e¡ect in young individuals by purifying tissues from ROS
overproducing cells, while, on the other hand, it would impair
the survival of old individuals, thus reducing life span. If this
idea is correct, the activity of p66shc would represent a perfect
example of antagonistic pleiotropy (i.e. a factor that may ex-
ert bene¢cial e¡ects at early ages and detrimental e¡ects later
on). Should p66shc mitochondrial location be con¢rmed, an
additional evidence of the primary role of mitochondria in
aging and longevity would be obtained. To this regard, recent
data indicate that the mitochondrial controlled apoptosis can
be modulated by antioxidants, such as vitamin E [71], which
likely contribute to longevity, being the values of this antioxi-
dant signi¢cantly higher in centenarians than in elderly sub-
jects [72].
In conclusion, mitochondria would function as a ¢nely
tuned check point for many, if not all, the apoptotic path-
ways, where apoptotic and antiapoptotic signals converge and
integrate each other, leading to the decision to die or to sur-
vive, and, in any case, sending a variety of messages to nu-
clear and cytoplasmic targets. In this view, such an important
decision would be taken not by the nucleus, as the cell’s
‘brain’ ^ but rather by the mitochondrion, until now consid-
ered as a mere executioner. In this line, mitochondria would
a¡ect the aging process by the capacity to e⁄ciently eliminate
unwanted or damaged cells. When this capacity is impaired,
as in the case of aged cells, senescence of the organism even-
tually occurs. Moreover, it is conceivable that the putative
mitochondrial signalosome is involved also in cell homeosta-
sis, being responsible for a two way nucleusCmitochondrion
and mitochondrionCnucleus information exchange.
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